Edition:
India

Biocon Ltd (BION.NS)

BION.NS on National Stock Exchange of India

615.20INR
18 Apr 2019
Change (% chg)

Rs-7.30 (-1.17%)
Prev Close
Rs622.50
Open
Rs624.00
Day's High
Rs624.90
Day's Low
Rs612.40
Volume
804,519
Avg. Vol
1,452,961
52-wk High
Rs718.00
52-wk Low
Rs543.30

About

Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

RPT-ICRA ratings for Indian debt instruments-Mar 18

(Repeating to add more ratings) Mar 18 Below are the ratings awarded by Investment Information Credit Rating Agency Ltd. (ICRA) for local debt instruments as of March 15, 2019. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------ ---------- ------ ----- --------- SHORT TERM RATINGS: -----------------

19 Mar 2019

BUZZ-India's Biocon hits over 2-wk low; plant gets observations from U.S. FDA

** Biopharmaceutical company Biocon Ltd's shares fall as much as 3 pct to 607.05 rupees, their biggest intraday pct loss since Feb. 15

07 Mar 2019

Biocon quarterly profit more than doubles, beats estimate

Indian biotechnology firm Biocon Ltd's quarterly profit more than doubled, handily beating analysts' estimates, largely driven by strong performance of its biologics businesses.

24 Jan 2019

India's Biocon quarterly profit more than doubles, beats estimate

Jan 24 Indian biotechnology firm Biocon Ltd's quarterly profit more than doubled, handily beating analysts' estimates, largely driven by strong performance of its biologics businesses.

24 Jan 2019

Biocon second-quarter profit surges on one-off gain

Indian biotechnology company Biocon Ltd posted an over five-fold rise in second-quarter profit on Thursday, as the company recorded a one-off gain of 1.89 billion rupees ($25.79 million).

25 Oct 2018

CORRECTED-India's Biocon Q2 profit surges on one-off gain

Oct 25 Indian biotechnology company Biocon Ltd posted an over five-fold rise in second-quarter profit on Thursday, as the company recorded a one-off gain of 1.89 billion rupees ($25.79 million).

25 Oct 2018

Earnings vs. Estimates

No consensus analysis data available.